27.06.2013 • News

Michael Spagnol New Novasep President and CEO

Michel Spagnol has been appointed president and CEO of Novasep.
Michel Spagnol has been appointed president and CEO of Novasep.

Michel Spagnol has been appointed president and CEO of Novasep; he succeeds Patrick Glaser. Spagnol was most recently president and chief technology officer of Shasun; previously, he held several positions at Rhodia, including sales and marketing VP of Rhodia Pharma Solutions.

Novasep has also recently announced several investments in France and China. The company plans to build the world's largest build the world's largest chromatography plant dedicated to the pharmaceutical industry in Le Mans and is expanding its manufacturing anti-cancer therapies capabilities in Shanghai to serve the Asian market.

"Novasep is on the right track for continued growth and expansion with promising projects which will enable us to continue delivering value-added solutions for our global customers," Spagnol said.

 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.